RecruitingPhase 1 / Phase 2NCT07439094
A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer
Sponsor: Chong Kun Dang Pharmaceutical
Ohio City, OH
1 recruiting lung cancer studies with a site in Ohio City, OH.
Sponsor: Chong Kun Dang Pharmaceutical
Ohio City, OH
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.